ここから本文です

こんなの拾った。特許ってそれも外国のって意味が分からない...

Title: NOVEL PHARMACEUTICAL USES(新しい医薬用途?)
Document Type and Number: United States Patent Application 20190070159
Kind Code: A1(公開特許?)
Current Assignee: Takeda Pharmaceutical Co Ltd
Abstract: The invention provides a potassium-competitive acid blocker (P-CAB) for use in the treatment, prevention and/or reduction of gastro-esophageal reflux disease (GERD) symptoms in patients who are partial responders to a proton pump inhibitor (PPI). The P-CAB may, for example, be selected from 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine (vonoprazan), revaprazan (YH1855), YH4808, RQ-4 and CS-526, or a salt thereof.
Publication Date: 03/07/2019(3月7日)
(以下略)